Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

179
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
179
Crossover Experiments01:16

Crossover Experiments

4.5K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.5K
Cochran's Q Test01:17

Cochran's Q Test

955
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
955
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

553
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
553
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

194
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
194

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Engagement With Open Notes Following the 21st Century Cures Act.

JAMA health forum·2026
Same author

Health Equity: JAMA Internal Medicine Call for Papers.

JAMA internal medicine·2026
Same author

The Delivery Disconnect: Why We Could Not Model the Impact of Foreign Aid Reductions on Vertical HIV Transmission and What Remains Evident About Strategic Priorities.

Journal of the International AIDS Society·2026
Same author

Identifying and Categorizing Diagnostic Errors in Abdominal Imaging Using a Diagnostic Imaging-Specific Annotation Process.

Journal of the American College of Radiology : JACR·2026
Same author

Response to: 'Methodological concerns on prostate-specific membrane antigen (PSMA) immunohistochemistry for predicting PSMA-PET avidity'.

BJU international·2026
Same author

How Big Is the "Gray Area"? Navigating Health-Threatening Previability Pregnancy Complications in States With Abortion Restrictions.

Annals of internal medicine·2026

Related Experiment Video

Updated: Jan 15, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Difference-in-Differences for Health Policy and Practice: A Review of Modern Methods.

Shuo Feng1, Ishani Ganguli2, Youjin Lee1

  • 1Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA.

Statistics in Medicine
|October 7, 2025
PubMed
Summary
This summary is machine-generated.

This review synthesizes best practices and innovations in difference-in-differences (DiD) causal inference for health policy. It offers guidance on assessing assumptions, adjusting for covariates, handling staggered timing, and robust inference.

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Related Experiment Videos

Last Updated: Jan 15, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Area of Science:

  • Health Policy Research
  • Observational Causal Inference
  • Econometrics in Medicine

Background:

  • Difference-in-differences (DiD) is a key method for evaluating health policies and programs.
  • The validity of DiD hinges on the parallel trends assumption.
  • Recent advancements necessitate updated best practices for DiD application in health.

Purpose of the Study:

  • To review and synthesize best practices and recent innovations in DiD methods for health policy and medicine.
  • To provide practical recommendations for researchers implementing DiD.
  • To address challenges and common pitfalls in traditional DiD analysis.

Main Methods:

  • Focused literature review of medical DiD studies.
  • Synthesis of best practices and recent methodological advancements.
  • Categorization of recommendations into four key areas: assumption assessment, covariate adjustment, staggered treatment timing, and robust inference.

Main Results:

  • Identified key challenges in assessing causal assumptions for DiD.
  • Recommended methods for adjusting for covariates to relax causal assumptions.
  • Highlighted strategies for accounting for staggered treatment timing in DiD.
  • Provided guidance on robust inference techniques when standard errors are inappropriate.

Conclusions:

  • Adoption of recommended practices can improve the rigor of DiD studies in health policy.
  • Addressing methodological nuances is crucial for accurate causal inference in observational health research.
  • This review supports effective implementation of advanced DiD methods in health research.